Skip to content

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

A 16-Week Growth Study of an Extensively Hydrolyzed Infant Formula, 3 Months Treatment and 1 Month Follow-up for a Duration of 4 Months.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00936637
Enrollment
35
Registered
2009-07-10
Start date
2007-07-31
Completion date
2008-12-31
Last updated
2009-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth

Brief summary

The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.

Interventions

OTHERExtensively hydrolyzed infant formula

Sponsors

Perrigo Nutritionals
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
1 Days to 21 Days
Healthy volunteers
Yes

Inclusion criteria

* At birth: * Healthy, term (37-42 weeks) infant * Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts * At time of enrollment: * \< or = 21 days post-natal age * Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts * Exclusively formula fed * Written informed consent of parent/guardian

Exclusion criteria

* At the time of enrollment: partially human-milk fed; fed baby/solid foods * Conditions requiring feedings other than those specified in the protocol * Documented or suspected cow's milk allergy and/or soy protein allergies * Major congenital deformities * Suspected or documented systemic or congenital infections * Evidence of cardiac, respiratory, hematological, gastrointestinal, or other systemic diseases * Participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
An extensively hydrolyzed formula is nutritionally adequate for normal growth of healthy full-term infants16 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026